Clinical Trial: Efficacy and Durability of a Personalized Treat-and-extend Regimen of Faricimab for Treatment-naive Polypoidal Choroidal Vasculopathy

U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT07461441) titled 'Efficacy and Durability of a Personalized Treat-and-extend Regimen of Faricimab for Treatment-naive Polypoidal Choroidal Vasculopathy' on Feb. 14.

Brief Summary: To evaluate the Efficacy of a personalized treat-and-extend regimen of faricimab for treatment-naive polypoidal choroidal vasculopathy

Study Start Date: March 01

Study Type: INTERVENTIONAL

Condition: Polypoidal Choroidal Vasculopathy (PCV) Age Related Macular Degeneration

Intervention: DRUG: Faricimab Injection [Vabysmo]

After applying topical anesthetic drops, intravitreal injections were delivered with a 30-gauge needle placed 3.5-4.0 mm posterior to the limbus. P...